Navigation Links
Breast Cancer Detection and Treatment Recovers Slowly from Big Losses During Recession
Date:6/25/2012

FARMINGTON, Conn., June 25, 2012 /PRNewswire-iReach/ -- Breast Cancer Diagnostic and Drug market are recovering after significant slowdown during the global recession. Having accurate market data and analysis will be essential to companies seeking to compete on the global stage as the market reemerges into success. With premium market research from the world's leading publishers, Global Information Inc. helps businesses stay on the cutting edge with the best forecasts, research, and analyses.

(Photo: http://photos.prnewswire.com/prnh/20120625/CG29841)

Breast Cancer Diagnostic and Drug Technologies: Global Markets

The global market for breast cancer diagnostics and drug technologies shrank significantly in 2011. The predictive breast cancer diagnostic and drug technology market was valued at $23.4 billion in 2010 and came down to $21.2 billion in 2011, while the Breast cancer drug market size reached $12.7 billion in 2010 and came down to $10.2 billion in 2011. The only market to show modest growth was the quantitative immunofluorescence market, which reached $5.7 billion in 2010 and $5.9 billion in 2011 respectively. This market also shows the biggest growth potential, with forecast CAGR of 3.1% by 2016, while breast cancer drugs will reach $11.2 billion by 2016 at a CAGR of 1.9%.

In their new report "Breast Cancer Diagnostic and Drug Technologies: Global Markets", BCC offers a comprehensive review of emerging breast cancer personalized and predictive diagnostic tests, particularly with regard to companion tests, tumor markers and gene profiling assays relevant for breast cancer prognosis and diagnosis; including SWOT analysis and market review. The report also reviews the current state of the companion diagnostics industry and the new technologies in assay development, and describes an overview of major biotechnology and pharmaceutical companies involved in developing innovative, targeted breast cancer treatments. In addition, the report also provides information regarding the less-developed sectors of this market and presents a list of current companies that have new predictive testing products and drugs in development for breast cancer.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/bc245536-breast-cancer-diagnostic-drug-technologies-global.html

Breast Cancer Partnering 2007-2012

"Breast Cancer Partnering 2007-2012" provides access to the breast cancer partnering deals and agreements entered into by the world's leading healthcare companies, including analysis by industry sector, stage of development, and technology type. The report contains over 250 links to online copies of actual breast cancer deals and contract documents, offering details insight press releases do not disclose.

The report includes a comprehensive directory of breast cancer partnering deals signed and announced since 2007. Leading breast cancer deals are listed by value, industry sector, Stage of development at signing, Deal component and technology type.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/wild233895-breast-cancer-partnering-2007-2012.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
2. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
3. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
4. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
5. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
6. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
8. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
9. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
10. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
11. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- Breast Cancer Therapeutics in Asia-Pacific Markets to ... (APAC) breast cancer market will experience considerable expansion from ... a Compound Annual Growth Rate (CAGR) of 8.5%. --> ... - states that the Asia-Pacific (APAC) ... in 2014 to $3.4 billion by 2021, at a Compound ...
(Date:2/11/2016)... , February 11, 2016 ... at Worldwide Clinical Trials, will present at this year,s Summit ... the Hyatt Regency in Miami, FL. ... partnerships to optimize study execution, supporting SCOPE,s "Improving Site Study ... take place on Thursday, Feb. 25 at 11:05 a.m. ...
(Date:2/11/2016)... , Feb. 11, 2016 Exactus ... company providing high-quality specialty pharmacy care for those ... today it has achieved full Specialty Pharmacy Accreditation ... organization dedicated to promoting health care quality through ... --> The URAC accreditation process ...
Breaking Medicine Technology:
(Date:2/12/2016)... SAN LUIS OBISPO, Calif. (PRWEB) , ... February 12, 2016 , ... The Central Coast ... purpose of this dance is to provide a night of fun for teens with and ... to help everyone feel welcomed and included at the event. The dance will take place ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Basketball is a ... integral part of the Peety PoppersTM series, sign language translation is featured in the ... health and wellness in Peety PoppersTM lessons has a sign language translator to teach ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Dignity Health named ... Hospital Emergency Room –Mesa. The new facility is licensed under Dignity Health ... “Dr. Bingham is an excellent leader and will ensure our new freestanding emergency room ...
(Date:2/11/2016)... CA (PRWEB) , ... February 11, 2016 , ... According ... System, a product marketed as a weight loss dietary supplement, is being recalled due ... group Beverly Hills Physicians, because there is not a single supplement on the market ...
(Date:2/11/2016)... ... 2016 , ... Registered nurses, licensed practical nurses and nursing aides who treat ... Act, Time to Heal” on Thursday, February 25 from 9:00 to 11:00 a.m. at ... Chedda, president of ANSA Consultants, who will discuss clinical best practices throughout the continuum ...
Breaking Medicine News(10 mins):